The 2026 Biologics Wave: Which Innovations Will Break Through?
The biopharmaceutical landscape continues to evolve at a remarkable pace, driven by breakthroughs in targeted therapies, novel modalities, and a deepening understanding of disease mechanisms. As we approach 2026, the anticipated approvals of innovative …